Elevance Health EBITDA 2010-2024 | ELV
Elevance Health annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Elevance Health EBITDA for the quarter ending December 31, 2024 was $2.002B, a 14.41% decline year-over-year.
- Elevance Health EBITDA for the twelve months ending December 31, 2024 was $10.822B, a 2.55% increase year-over-year.
- Elevance Health 2023 annual EBITDA was $10.49B, a 3.59% increase from 2022.
- Elevance Health 2022 annual EBITDA was $10.126B, a 0.1% increase from 2021.
- Elevance Health 2021 annual EBITDA was $10.116B, a 23.19% increase from 2020.
| Elevance Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $10,490 |
| 2022 | $10,126 |
| 2021 | $10,116 |
| 2020 | $8,212 |
| 2019 | $7,866 |
| 2018 | $6,964 |
| 2017 | $5,876 |
| 2016 | $6,190 |
| 2015 | $6,183 |
| 2014 | $5,901 |
| 2013 | $5,497 |
| 2012 | $5,111 |
| 2011 | $5,025 |
| 2010 | $5,374 |
| 2009 | $8,404 |
| Elevance Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $2,002 |
| 2024-06-30 | $3,601 |
| 2024-03-31 | $3,535 |
| 2023-12-31 | $1,684 |
| 2023-09-30 | $2,339 |
| 2023-06-30 | $3,135 |
| 2023-03-31 | $3,332 |
| 2022-12-31 | $1,747 |
| 2022-09-30 | $2,791 |
| 2022-06-30 | $2,723 |
| 2022-03-31 | $2,865 |
| 2021-12-31 | $2,046 |
| 2021-09-30 | $2,548 |
| 2021-06-30 | $2,872 |
| 2021-03-31 | $2,650 |
| 2020-12-31 | $1,094 |
| 2020-09-30 | $925 |
| 2020-06-30 | $3,639 |
| 2020-03-31 | $2,554 |
| 2019-12-31 | $1,537 |
| 2019-09-30 | $1,975 |
| 2019-06-30 | $1,934 |
| 2019-03-31 | $2,420 |
| 2018-12-31 | $1,013 |
| 2018-09-30 | $1,717 |
| 2018-06-30 | $1,981 |
| 2018-03-31 | $2,253 |
| 2017-12-31 | $798 |
| 2017-09-30 | $1,493 |
| 2017-06-30 | $1,614 |
| 2017-03-31 | $1,971 |
| 2016-12-31 | $1,068 |
| 2016-09-30 | $1,538 |
| 2016-06-30 | $1,860 |
| 2016-03-31 | $1,724 |
| 2015-12-31 | $778 |
| 2015-09-30 | $1,263 |
| 2015-06-30 | $2,201 |
| 2015-03-31 | $1,941 |
| 2014-12-31 | $1,249 |
| 2014-09-30 | $1,525 |
| 2014-06-30 | $1,630 |
| 2014-03-31 | $1,496 |
| 2013-12-31 | $853 |
| 2013-09-30 | $1,408 |
| 2013-06-30 | $1,588 |
| 2013-03-31 | $1,648 |
| 2012-12-31 | $819 |
| 2012-09-30 | $1,346 |
| 2012-06-30 | $1,348 |
| 2012-03-31 | $1,598 |
| 2011-12-31 | $771 |
| 2011-09-30 | $1,305 |
| 2011-06-30 | $1,266 |
| 2011-03-31 | $1,684 |
| 2010-12-31 | $1,023 |
| 2010-09-30 | $1,399 |
| 2010-06-30 | $1,377 |
| 2010-03-31 | $1,574 |
| 2009-12-31 | $4,580 |
| 2009-09-30 | $1,367 |
| 2009-06-30 | $1,311 |
| 2009-03-31 | $1,145 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $90.566B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| Cencora (COR) | United States | $47.211B | 17.13 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $22.205B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |